GlassScriptPhysician profile
Nhu Q Pham
NPI 1396776977
$1,224.22
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $372 · 2021: $114 · 2022: $40.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $338.09 | 2019-2021 | |
| Pfizer INC. | $244.87 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $92.30 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $73.71 | 2019 | |
| Merck Sharp & Dohme LLC | $68.52 | 2019-2020 | |
| Glaxosmithkline, LLC. | $66.88 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.61 | 2019-2021 | |
| Kaleo, INC. | $39.51 | 2019 | |
| Sobi, INC | $38.68 | 2019 | |
| Adlon Therapeutics L.P. | $36.36 | 2019 | |
| Bausch Health US, LLC | $28.41 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $25.01 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.12 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.38 | 2020 | |
| Hologic Sales and Service, LLC | $21.04 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $19.94 | 2020 | |
| Allergan, INC. | $18.02 | 2020 | |
| Avion Pharmaceuticals | $14.77 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nhu Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.